CLX — Stock Film
STOCK FILMSCENE 1/11CLX · $106
Stock Expert AI presents
CLX
The Clorox Company
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
The Clorox Company. A quick introduction.

On the stock market since 1983, it operates in the everyday-essentials business. It has 7,600 employees. Now — the numbers.

on the stock market since 1983
7,600 employees
$12B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $9 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 9%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
40%Health and Wellness
Health and Wellness 40%Household 27%Lifestyle 17%Other 17%
40% of all revenue comes from a single line: Health and Wellness.

Revenue is spread across several lines; no single product carries the company.

Cash on hand:
$0
Total debt:
$0
The debt outweighs the cash.

The gap is $5.4B. In times of high interest rates, a gap like that can squeeze a company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
63
average

Profit indicators sit around the sector average.

FINANCIAL STRENGTH
14
very weak

Clearly below the class average.

VALUATION
31
very weak

Clearly below the class average.

GROWTH
34
very weak

Clearly below the class average.

PRICE MOMENTUM
59
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 2 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking8/10
WEAK SPOTS
The stock has lost its spark0/10
THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 43% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/2
Executives are buying their own stock

Over the last 12 months, company executives reported 60 buys and 29 sells. Management buying with its own money is usually read as a good sign.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $4.96 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
Sales are shrinking

Over the last 3 years, sales fell about 3% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 14/100.

3
THE RISKS · 3/3
The price runs ahead of the earnings

Today’s price already includes part of tomorrow’s optimism. Report-card grade: 31/100.

FINALE · THE GRADE
D
0 / 100 · MoonshotScore

On our five-subject report card, CLX sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”

The takeaway: CLX is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film